Dupont Capital Management Corp Maravai Lifesciences Holdings, Inc. Transaction History

Dupont Capital Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$12.5 - $24.78 $49,850 - $98,822	3,988 Added 13.35%	33,857 $0
Q3 2022 Oct 31, 2022	BUY	$20.6 - $30.37 $42,271 - $62,319	2,052 Added 7.38%	29,869 $763,000
Q2 2022 Jul 26, 2022	BUY	$26.05 - $37.48 $61,321 - $88,227	2,354 Added 9.24%	27,817 $790,000
Q1 2022 Apr 27, 2022	SELL	$24.46 - $40.92 $403,736 - $675,425	-16,506 Reduced 39.33%	25,463 $898,000
Q4 2021 Jan 31, 2022	BUY	$35.0 - $45.94 $1.4 Million - $1.84 Million	40,113 Added 2161.26%	41,969 $1.76 Million

Q3 2021 Nov 03, 2021	SELL	$36.8 - $60.62 $350,262 - $576,981	-9,518 Reduced 83.68%	1,856 $91,000
Q2 2021 Jul 30, 2021	BUY	$32.46 - $45.0 $369,200 - $511,830	11,374 New	11,374 $475,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.